KalVista Pharmaceuticals Statistics
Total Valuation
KALV has a market cap or net worth of $798.13 million. The enterprise value is $745.12 million.
Important Dates
The last earnings date was Monday, November 10, 2025, before market open.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KALV has 50.55 million shares outstanding. The number of shares has increased by 29.51% in one year.
| Current Share Class | 50.55M |
| Shares Outstanding | 50.55M |
| Shares Change (YoY) | +29.51% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 2.20% |
| Owned by Institutions (%) | 80.92% |
| Float | 30.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 559.70 |
| Forward PS | 9.90 |
| PB Ratio | 19.49 |
| P/TBV Ratio | 19.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 522.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 3.39.
| Current Ratio | 5.37 |
| Quick Ratio | 5.16 |
| Debt / Equity | 3.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.79 |
Financial Efficiency
Return on equity (ROE) is -190.18% and return on invested capital (ROIC) is -70.75%.
| Return on Equity (ROE) | -190.18% |
| Return on Assets (ROA) | -60.98% |
| Return on Invested Capital (ROIC) | -70.75% |
| Return on Capital Employed (ROCE) | -114.49% |
| Revenue Per Employee | $5,281 |
| Profits Per Employee | -$752,211 |
| Employee Count | 270 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KALV has paid $5.55 million in taxes.
| Income Tax | 5.55M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +78.82% in the last 52 weeks. The beta is -0.14, so KALV's price volatility has been lower than the market average.
| Beta (5Y) | -0.14 |
| 52-Week Price Change | +78.82% |
| 50-Day Moving Average | 13.40 |
| 200-Day Moving Average | 12.99 |
| Relative Strength Index (RSI) | 57.09 |
| Average Volume (20 Days) | 1,397,339 |
Short Selling Information
The latest short interest is 15.39 million, so 30.44% of the outstanding shares have been sold short.
| Short Interest | 15.39M |
| Short Previous Month | 14.43M |
| Short % of Shares Out | 30.44% |
| Short % of Float | 50.65% |
| Short Ratio (days to cover) | 9.82 |
Income Statement
In the last 12 months, KALV had revenue of $1.43 million and -$203.10 million in losses. Loss per share was -$3.95.
| Revenue | 1.43M |
| Gross Profit | -59.42M |
| Operating Income | -202.79M |
| Pretax Income | -197.55M |
| Net Income | -203.10M |
| EBITDA | -201.82M |
| EBIT | -202.79M |
| Loss Per Share | -$3.95 |
Full Income StatementBalance Sheet
The company has $191.47 million in cash and $138.46 million in debt, giving a net cash position of $53.00 million or $1.05 per share.
| Cash & Cash Equivalents | 191.47M |
| Total Debt | 138.46M |
| Net Cash | 53.00M |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 40.79M |
| Book Value Per Share | 0.81 |
| Working Capital | 167.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$167.19 million and capital expenditures -$703,000, giving a free cash flow of -$167.89 million.
| Operating Cash Flow | -167.19M |
| Capital Expenditures | -703,000 |
| Free Cash Flow | -167.89M |
| FCF Per Share | -$3.32 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -14,220.83% |
| Pretax Margin | -13,853.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KALV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.51% |
| Shareholder Yield | -29.51% |
| Earnings Yield | -25.45% |
| FCF Yield | -21.04% |
Analyst Forecast
The average price target for KALV is $27.17, which is 72.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.17 |
| Price Target Difference | 72.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KALV has an Altman Z-Score of -4.92 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.92 |
| Piotroski F-Score | 1 |
